MariMed Inc. (OTCMKTS:MRMD) Sees Large Drop in Short Interest

MariMed Inc. (OTCMKTS:MRMD) was the target of a large decline in short interest in June. As of June 30th, there was short interest totaling 1,866 shares, a decline of 88.4% from the June 15th total of 16,030 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 668,174 shares, the days-to-cover ratio is presently 0.0 days.

MariMed Price Performance

MRMD stock traded up $0.00 during midday trading on Friday, reaching $0.07. 101,528 shares of the company’s stock traded hands, compared to its average volume of 554,791. The company has a 50-day simple moving average of $0.07 and a two-hundred day simple moving average of $0.08. The company has a quick ratio of 0.34, a current ratio of 0.95 and a debt-to-equity ratio of 1.67. MariMed has a 1-year low of $0.06 and a 1-year high of $0.23. The company has a market cap of $27.15 million, a price-to-earnings ratio of -2.27 and a beta of 1.32.

MariMed (OTCMKTS:MRMD) last announced its earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.The company had revenue of $39.48 million for the quarter, compared to analysts’ expectations of $38.75 million. On average, analysts anticipate that MariMed will post -0.04 earnings per share for the current year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.